We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.72%
2 Healthcare 11.35%
3 Financials 9.44%
4 Consumer Discretionary 8.31%
5 Communication Services 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMTK
4826
DELISTED
DermTech, Inc. Common Stock
DMTK
$832K ﹤0.01%
210,228
-124,034
-37% -$763K
SDC
4827
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$830K ﹤0.01%
915,926
-269,247
-23% -$327K
NVTS icon
4828
Navitas Semiconductor
NVTS
$3.77B
$828K ﹤0.01%
170,712
+36,462
+27% +$189K
EPR.PRC icon
4829
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$148M
$824K ﹤0.01%
46,644
+5,059
+12% +$113K
MFGP
4830
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$824K ﹤0.01%
144,654
-80,700
-36% -$350K
AMRX icon
4831
Amneal Pharmaceuticals
AMRX
$6.32B
$823K ﹤0.01%
407,509
-54,911
-12% -$154K
ARDX icon
4832
Ardelyx
ARDX
$1.05B
$823K ﹤0.01%
691,456
+294,034
+74% +$280K
KRON
4833
DELISTED
Kronos Bio
KRON
$822K ﹤0.01%
245,650
+31,854
+15% +$144K
CTEX icon
4834
ProShares S&P Kensho Cleantech ETF
CTEX
$5.36M
$820K ﹤0.01%
+25,000
New +$878K
EXFY icon
4835
Expensify
EXFY
$210M
$815K ﹤0.01%
54,745
+23,705
+76% +$442K
TBLD
4836
Thornburg Income Builder Opportunities Trust
TBLD
$720M
$815K ﹤0.01%
63,963
+29,586
+86% +$432K
AIM
4837
AIM ImmunoTech
AIM
$6.69M
$814K ﹤0.01%
13,998
-2,011
-13% -$141K
OYST
4838
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$812K ﹤0.01%
144,528
+477
+0.3% +$2.99K
CSD icon
4839
Invesco S&P Spin-Off ETF
CSD
$237M
$811K ﹤0.01%
17,028
+448
+3% +$23.7K
BKCC
4840
DELISTED
BlackRock Capital Investment Corporation
BKCC
$811K ﹤0.01%
239,410
+6,861
+3% +$26.2K
AEF
4841
abrdn Emerging Markets Equity Income Fund
AEF
$387M
$809K ﹤0.01%
176,687
-16,193
-8% -$85.8K
LASR icon
4842
nLIGHT
LASR
$3.03B
$808K ﹤0.01%
85,501
-16,815
-16% -$194K
NRGV icon
4843
Energy Vault
NRGV
$687M
$808K ﹤0.01%
152,937
+30,118
+25% +$164K
POWW icon
4844
Outdoor Holding Co
POWW
$260M
$808K ﹤0.01%
275,657
-7,155
-3% -$30.6K
MOR
4845
DELISTED
MorphoSys AG American Depositary Shares
MOR
$808K ﹤0.01%
160,552
-15,100
-9% -$78K
NGMS
4846
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$804K ﹤0.01%
62,340
+14,609
+31% +$222K
SMBK icon
4847
SmartFinancial
SMBK
$902M
$803K ﹤0.01%
32,542
+442
+1% +$11.2K
INMB icon
4848
INmune Bio
INMB
$60.2M
$800K ﹤0.01%
129,000
-79,282
-38% -$696K
DHF
4849
BNY Mellon High Yield Strategies Fund
DHF
$174M
$798K ﹤0.01%
378,579
-103,874
-22% -$240K
AHT
4850
Ashford Hospitality Trust
AHT
$20.8M
$796K ﹤0.01%
11,690
-2,140
-15% -$190K

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.